dem 20 F:
Zitatanfang:
"Future issuances of securities and hedging activities may depress the trading price of our Common Shares.
Any additional or future issuance of Common Shares or Convertible Securities, including the issuance of Common Shares upon the exercise of stock options and upon the exercise of warrants, could dilute the interests of our existing shareholders, and could substantially decrease the trading price of our Common Shares. We may issue equity securities in the future for a number of reasons, including to finance our operations and business strategy, to satisfy our obligations upon the exercise of options or warrants or for other reasons. Our Stock Option Plan generally permits us to have outstanding, at any given time, stock options that are exercisable for a maximum number of Common Shares equal to 11.4% of all then issued and outstanding Common Shares. As at March 29, 2016, there were:
•§9,928,697 Common Shares issued and outstanding;
•§no issued and outstanding Preferred Shares;
•§2,842,309 Common Shares issuable upon exercise of outstanding warrants (excluding any exercises of Series B Warrants under the alternate cashless exercise feature of such warrants); and
•§275,041 stock options outstanding."
Zitatende
Gefunden hier:
ir.aezsinc.com/regulatory-filings/all/2016/all
Das riecht nach weiterer Dilution, quasi nach dem Motto: Nach der Dilution ist VOR der Dilution...
Schade schade dass AEZS wohl weiter auf Kosten der Shareholder weiter werkelt.
Der Kauf von Dodd scheint zu ner Nebelkerze zu werden...
Ich hoffe sehr dass ich mich täusche!
mfg. copy